CA2534871C - Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide - Google Patents

Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide Download PDF

Info

Publication number
CA2534871C
CA2534871C CA2534871A CA2534871A CA2534871C CA 2534871 C CA2534871 C CA 2534871C CA 2534871 A CA2534871 A CA 2534871A CA 2534871 A CA2534871 A CA 2534871A CA 2534871 C CA2534871 C CA 2534871C
Authority
CA
Canada
Prior art keywords
leu
arg
ser
ala
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2534871A
Other languages
English (en)
Other versions
CA2534871A1 (fr
Inventor
Charis Eng
Frank Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Ohio State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University Research Foundation filed Critical Ohio State University Research Foundation
Priority to CA2534871A priority Critical patent/CA2534871C/fr
Publication of CA2534871A1 publication Critical patent/CA2534871A1/fr
Application granted granted Critical
Publication of CA2534871C publication Critical patent/CA2534871C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Des méthodes d'identification de tissus thyroïdiens malins comprennent un test d'un échantillon de tissu thyroïdien en vue d'identifier l'expression d'au moins deux gènes parmi les CCND2, PCSK2 et PLAB. Les trousses servant aux méthodes présentées sont également fournies.
CA2534871A 2006-02-15 2006-02-15 Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide Expired - Fee Related CA2534871C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2534871A CA2534871C (fr) 2006-02-15 2006-02-15 Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2534871A CA2534871C (fr) 2006-02-15 2006-02-15 Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide

Publications (2)

Publication Number Publication Date
CA2534871A1 CA2534871A1 (fr) 2007-08-15
CA2534871C true CA2534871C (fr) 2015-08-04

Family

ID=38421204

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2534871A Expired - Fee Related CA2534871C (fr) 2006-02-15 2006-02-15 Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide

Country Status (1)

Country Link
CA (1) CA2534871C (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2896076C (fr) 2012-12-21 2022-12-06 Aveo Pharmaceuticals, Inc. Anticorps anti-gdf15
EP3034620A1 (fr) * 2014-12-17 2016-06-22 Diaxonhit Compositions et procédés permettant de diagnostiquer un cancer de la thyroïde
CN109321645A (zh) * 2018-10-23 2019-02-12 深圳市慧思基因科技有限公司 一种端粒酶催化蛋白亚单位hTERT活性的检测方法
CN113222928B (zh) * 2021-05-07 2023-09-19 北京大学第一医院 一种尿细胞学人工智能尿路上皮癌识别系统
CN118480605A (zh) * 2024-05-10 2024-08-13 南方科技大学 Ret/ptc与tert突变共存的遗传标志物及相关通路抑制剂的应用

Also Published As

Publication number Publication date
CA2534871A1 (fr) 2007-08-15

Similar Documents

Publication Publication Date Title
US7670775B2 (en) Method for differentiating malignant from benign thyroid tissue
Weber et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination
JP7156650B2 (ja) 胃がんの検出キット又はデバイス及び検出方法
EP2227568B1 (fr) Diagnostic moléculaire in vitro du cancer du sein
CN115927612B (zh) 检测食管疾病
Pulkkinen et al. A homozygous nonsense mutation in the β3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa
EP2126121B1 (fr) Procédé de détection d'un cancer du foie, d'un risque de cancer du foie, d'un risque de récidive de cancer du foie, de la malignité d'un cancer du foie et de la progression d'un cancer du foie dans le temps en utilisant la cytosine méthylée dans le gène basp1
EP2420575B1 (fr) Marqueur pronostique du cancer du foie
US20060088870A1 (en) Topographic genotyping for determining the diagnosis, malignant potential, and biologic behavior of pancreatic cysts and related conditions
EP4060048A2 (fr) Procédé de diagnostic non invasif pour diagnostiquer un cancer de la vessie
BRPI0708534A2 (pt) ensaio molecular para prognosticar a recorrência de cáncer do cólon dukes b
JP2017525977A (ja) 細胞増殖性異常検出用または疾患程度等級付け用の遺伝子組成物およびその用途
EP2215258A1 (fr) Procédé de diagnostic de néoplasmes
EP2434024A1 (fr) Marqueurs urinaires permettant de detecter un cancer de la vessie
KR20100120657A (ko) Ⅱ기 및 ⅲ기 결장암의 분자적 병기 및 예후
CA2504403A1 (fr) Pronostic d'une malignite hematologique
EP3129509B1 (fr) Procédés et kits d'identification de polypes colorectaux précancéreux et du cancer colorectal
CN114107498B (zh) 结直肠癌血液检测标记物及其应用
JP2008528001A (ja) 癌マーカーおよび検出方法
CA2534871A1 (fr) Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide
KR101774747B1 (ko) Ｐｃａｆ의 다형성을 이용한 비소세포폐암의 예후 진단 방법
KR102052398B1 (ko) 전립선암 진단용 바이오마커 및 이의 용도
KR102384992B1 (ko) 대장암 환자의 연령 특이적 바이오마커 및 이의 용도
JP5410722B2 (ja) 膵臓の組織傷害あるいは細胞増殖性疾患の検出方法
CN106574306A (zh) 用于预测对靶向抗癌药物的接受性的方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20210831

MKLA Lapsed

Effective date: 20200217